Article
Somatic mutations of activating signalling, transcription factor, and tumour suppressor are a precondition for leukaemia transformation in myelodysplastic syndromes.
Journal of cellular and molecular medicine - 1 Dec 2022
Xu Feng, Wu Lin-Yun, Guo Juan, He Qi, Zhang Zheng, Li Xiao
Abstract excerpt
The transformation biology of secondary acute myeloid leukaemia (AML) from myelodysplastic syndromes (MDSs) is still not fully understood. We performed paired self-controlled sequencing, including targeted, whole exome, and single-cell RNA sequencing, in a cohort of MDS patients to search for AML transformation-related mutations (TRMs). Thirty-nine target genes from paired samples from 72 patients with MDS who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
